Skip to main content

A second loss for AbbVie's AndroGel, slammed with $140 Million

A second loss for AbbVie's AndroGel, slammed with $140 Million

A second loss for AbbVie's AndroGel, slammed with $140 Million

Introduction

AbbVie faced a second loss in the Testosterone Replacement Therapy (TRT) bellwether trial when the jury announced a verdict of nearly $140 million in favor of the plaintiff. The verdict comprised of $140,000 as compensatory damages and $140 million as punitive damages. This was the second bellwether case to go to trial in the multidistrict litigation (MDL): 2545 in the District Court for the Northern District of Illinois, with over 6000 actions pending against AndroGel, Testim, Axiron, and other testosterone drug makers, presided by Judge Matthew F. Kennelly.
In this case, the manufacturer lost on the grounds of failing to warn the consumers and the medical community about the alleged link to heart attack and other side effects and that its aggressive marketing strategies risked the lives of thousands of men including the plaintiff, who suffered a heart attack just months after using AndroGel. AbbVie faced a small victory when claims were rejected by the jury in a state court in the month of August. AbbVie plans to appeal the $140 million verdict.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!